Effectiveness of Anti-Psychotic in GPs Setting
NCT00543088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2009-04-23
Summary
Evaluating the effectiveness of atypical antipsychotics in the community - a prospective, multicentre, observational study to evaluate the impact on Quality of Life of GP-based management of antipsychotic treatment in Belgium
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pitchot W Pr · ULg
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2008-06-30
Countries
- Belgium
Study Locations
More Related Trials
-
Subjective Well Being of Schizophrenic Patients in Greece
NCT00857064 ·Status: COMPLETED
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
NCT01164059 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731 ·Status: COMPLETED
-
The Effect of Sertindole on Sensory Gating and Cognition in Healthy Volunteers
NCT00612079 ·Status: COMPLETED ·Phase: NA
-
Study of Mental Care in Spain
NCT00824031 ·Status: COMPLETED
-
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
NCT01016145 ·Status: UNKNOWN ·Phase: PHASE4
-
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
NCT00230893 ·Status: COMPLETED
-
Safety and Tolerability of BI 409306 in Patients With Schizophrenia
NCT01892384 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms
NCT02529163 ·Status: UNKNOWN ·Phase: NA
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia
NCT04510298 ·Status: COMPLETED ·Phase: PHASE1
-
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718 ·Status: COMPLETED ·Phase: NA
-
A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly
NCT03809325 ·Status: COMPLETED
-
Study on the Efficacy and Safety of QLM1016 in Schizophrenia
NCT06799559 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
NCT03911726 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
NCT03356639 ·Status: COMPLETED ·Phase: PHASE1
-
Psychiatric Orders in Psychoanalytic Treatment of ASD
NCT05930912 ·Status: UNKNOWN
-
Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo
NCT00570063 ·Status: TERMINATED ·Phase: PHASE2
-
NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia
NCT00833456 ·Status: COMPLETED
-
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
NCT05958875 ·Status: RECRUITING ·Phase: PHASE4
-
Clinical Registry of Patients Under Treatment With Atypical Antipsychotics
NCT02409823 ·Status: COMPLETED
-
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
NCT04092686 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of a Tool for the Dimensional Assessment of Apathy in a Population Suffering From Schizophrenia.
NCT03801551 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
NCT00488163 ·Status: COMPLETED ·Phase: PHASE4